🇺🇸 Recombinant SARS-CoV-2 Ad5 vectored vaccine in United States

Recombinant SARS-CoV-2 Ad5 vectored vaccine (Recombinant SARS-CoV-2 Ad5 vectored vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Recombinant SARS-CoV-2 Ad5 vectored vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Recombinant SARS-CoV-2 Ad5 vectored vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Recombinant SARS-CoV-2 Ad5 vectored vaccine in United States?

Jiangsu Province Centers for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.